Professor, University of California, Riverside School of Public Policy. Faculty Director, Science to Policy (S2P). Public health scientist & sociologist keen on population health & community issues. Sometimes in the news, often for troubling topics. 🇺🇸 🇨🇦 .. more
Professor, University of California, Riverside School of Public Policy. Faculty Director, Science to Policy (S2P). Public health scientist & sociologist keen on population health & community issues. Sometimes in the news, often for troubling topics. 🇺🇸 🇨🇦
Reposted by Smith, Richard M. Carpiano
🛟 medsky sociology health policy
Reposted by Smith, Richard M. Carpiano, Simon Lester , and 1 more Smith, Richard M. Carpiano, Simon Lester, Timothy D. McBride
Meta claims this particular study was flawed. Ok, but if this is the only study, then approach is ignorance is bliss/plausible deniability. Still bad PR.
Was this really the only study? If they found other results suggesting null or positive effects, they'd be hyping them.
lailluminator.com/2025/02/18/a...
Reposted by Richard M. Carpiano
Dashes hopes for Novo Nordisk "that Alzheimer's could open a major new market for GLP-1 medicines such as semaglutide, as it faces rising competition to its blockbuster drugs in its core treatment areas of obesity and diabetes."
🛟🧪 Medsky sociology 😷
My recent incidents seem to be ppl treating their dogs like children. That's never good.
www.nationalacademies.org/news/stateme...
NIH is changing their policy so that staff have to prepare justification for every application that is funded BUT NO DOCUMENTATION FOR APPLICATIONS THAT ARE SKIPPED (BASED ON PERCENTILES).
1/2
Seen 3 cases in 24 hrs. (2 w/in 5 mins.). Mgr when I asked if it's legal: "No, but they do it anyway." Sec. guard was next to him. Worse when lines hold up as customers/staff fawn.